10 completed. 10 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
Follow levamlodipine: new trials by email Literature Review of levamlodipine trials Research Report on levamlodipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects Amlodipine 10 mg, Levamlodipine 5 mg - Healthy Subjects | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 48 | 2018-11-13 | 2020-06-05 |
| Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects Levamlodipine, Amlodipine, Amlodipine, Levamlodipine - Hypertension | Phase 1 | Completed | Conjupro Biotherapeutics, Inc. | 36 | 2018-05-31 | 2021-09-16 |
| CKD-828 (80/5mg) Pharmacokinetic Study CKD-828, Telmisartan, S-amlodipine - Hypertension | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 48 | 2015-02-01 | 2015-07-08 |
| CKD-828 (80/5mg) Pharmacokinetic Study CKD-828, Telmisartan, S-amlodipine - Hypertension | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 69 | 2014-09-01 | 2015-04-10 |
| Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg, atorvastatin 40mg - Essential Hypertension, Hyperlipidemia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2013-04-01 | 2013-08-01 |
| Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg, Telmisartan 80mg and S-amlodipine 5mg - Essential Hypertension, Hyperlipidemia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2013-04-01 | 2013-08-01 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60) Exforge tab. 10/160mg, Lodivixx tab. 5/160mg - Healthy Male Subjects | Phase 1 | Completed | Hanlim Pharm. Co., Ltd. | 53 | 2013-03-01 | 2018-08-03 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects Exforge tab. 10/160mg, Lodivixx tab. 5/160mg - Healthy Male Subjects | Phase 1 | Completed | Hanlim Pharm. Co., Ltd. | 40 | 2012-07-01 | 2013-03-26 |
| CKD-828 Drug Interaction Study (Telmisartan) Telmisartan 80mg, S-amlodipine 5mg, Telmisartan 80mg - Healthy Male Volunteers | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 32 | 2011-06-01 | 2011-09-07 |
| CKD-828 Drug Interaction Study (S-amlodipine) S-amlodipine 5mg,Telmisartan 80mg, S-amlodipine 5mg - Healthy Male Volunteers | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2011-05-01 | 2011-08-30 |
Hypertension (3) · Essential Hypertension (2) · Hyperlipidemias (2)
Chong Kun Dang Pharmaceutical (6) · Hanlim Pharm. Co., Ltd. (2) · Conjupro Biotherapeutics, Inc. (1) · The Affiliated Hospital of Qingdao University (1)
South Korea (8) · China (1) · United States (1)
Kyun S Bae, Ph.D. (2) · Young-Ran Yoon (2) · Jae Gook Shin, MD (1) · KyoungSook Kim, PhD (1) · Min Soo Park, Ph. D (1) · Min Soo Park, Ph.D (1)